Document Viewer
Share this page:
Title
Fact Sheet for Heath Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab
Subject
Description
Fact sheet for Bamlanivimab.
EUA: For the treatment of mild-to-moderate COVID-19 in adult and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
EUA: For the treatment of mild-to-moderate COVID-19 in adult and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
Date Last Updated (Year-Month-Day)
2020-11-09
Citation
Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/143603/download
Download Patients, Parents, and Caregivers Fact Sheet directly: https://www.fda.gov/media/143604/download
Descargue la hoja de datos de pacientes, padres y cuidadores en español directamente: https://www.fda.gov/media/143645/download
Download the Frequently Asked Questions on the Emergency Use Authorization for Bamlanivimab.